-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 23027 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBudCE4.1
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 4578
-
Vector typeMammalian Expression, Bacterial Expression
-
Selectable markersZeocin
Growth in Bacteria
-
Bacterial Resistance(s)Bleocin (Zeocin), 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsDH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameEGFP
-
Insert Size (bp)718
-
Entrez GeneeGFP (a.k.a. pPRS3a_01)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site KpnI (not destroyed)
- 3′ cloning site BglII (not destroyed)
- 5′ sequencing primer unknown (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byAs described in Roucou X, Giannopoulos PN, Zhang Y, Jodoin J, Goodyer CG, LeBlanc AC. Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells. Cell Death Differ. 2005, 12(7):783-795.
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Bigenic vector with EF-1alpha promoter and CMV promoter
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pBud-EGFP was a gift from Andrea LeBlanc (Addgene plasmid # 23027 ; http://n2t.net/addgene:23027 ; RRID:Addgene_23027) -
For your References section:
Loss of anti-Bax function in gerstmann-Straussler-Scheinker syndrome-associated prion protein mutants. Jodoin J, Misiewicz M, Makhijani P, Giannopoulos PN, Hammond J, Goodyer CG, LeBlanc AC. PLoS One. 2009 . 4(8):e6647. 10.1371/journal.pone.0006647 PubMed 19680558